Institute For Ethnomedicine Inc
- Assets
- $3.5m
- Revenue
- $2.0m
- Investments
- $22.3k
- Employees
- 6
- Location
- Jackson, WY
- Founding
- 04/2005
- Data as of
- 12/2023
- EIN
- 20-1829529
Organization Overview
Institute For Ethnomedicine Inc is located in Jackson, WY. The organization was established in 2005. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2023, Institute For Ethnomedicine Inc employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Ethnomedicine Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Institute For Ethnomedicine Inc generated $2.0m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 3.0% each year. All expenses for the organization totaled $2.7m during the year ending 12/2023. While expenses have increased by 2.2% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE INSTITUTE FOR ETHNOMEDICINE SEARCHES FOR NEW CURES BY STUDYING PLANT MEDICINE AND PATTERNS OF WELLNESS AND DISEASE AMONG INDIGENOUS PEOPLE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE BRAIN CHEMISTRY LABS SEEKS TO DISCOVER NOVEL WAYS OF PREVENTING, DIAGNOSING, AND TREATING BRAIN DISEASES. OUR CURRENT FOCUS IS ON PROGRESSIVE NEURODEGENERATIVE DISEASES CHARACTERIZED BY PROTEIN MISFOLDS, INCLUDING ALZHEIMERS, ALS, PARKINSONS, AND LEWY BODY DISEASE. WE ARE SPONSORING A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL OF THE AMINO ACID L-SERINE FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT (A PRECURSOR OF ALZHEIMERS DISEASE) AT HOUSTON METHODIST RESEARCH INSTITUTE. WE ARE CURRENTLY RAISING FUNDS FOR ADVANCED CLINICAL TRIALS OF L-SERINE FOR ALS, AND A CLINICAL TRIAL FOR WY40687, A NEW DRUG WE HAVE DISCOVERED FOR ADVANCED PARKINSONS DISEASE. WE HAVE DISCOVERED MICRORNA FINGERPRINTS, EXTRACTED FROM EXTRACELLULAR VESICLES IN THE BLOODSTREAM, WHICH ARE DIAGNOSTIC FOR ALS AS WELL AS A NOVEL METABOLITE WHICH IS DIAGNOSTIC FOR EARLY-STAGE ALZHEIMERS DISEASE. WE HAVE ALSO DISCOVERED THAT NATURALLY OCCURRING SMALL PROTEINS, CALLED CYCLOTIDES, MAY BE USEFUL AS CHEMOTHERAPY ADJUVANTS FOR GLIOBLASTOMA.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Paul Alan Cox PHD Executive Dir. | OfficerTrustee | 40 | $293,000 |
Sandra Banack Senior Scientist | 40 | $197,600 | |
Marilyn Asay Executive Assistan | 40 | $121,200 | |
Rachael Dunlop Sr Research Fellow | 40 | $125,238 | |
Stephen Boeschenstein Director | Trustee | 4 | $0 |
William C Egan III Board Chair | OfficerTrustee | 4 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,916,166 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,916,166 |
| Total Program Service Revenue | $30,402 |
| Investment income | $92,581 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $398 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,039,547 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $358,014 |
| Compensation of current officers, directors, key employees. | $77,922 |
| Compensation to disqualified persons | $60,000 |
| Other salaries and wages | $499,796 |
| Pension plan accruals and contributions | $48,440 |
| Other employee benefits | $126,539 |
| Payroll taxes | $49,775 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $259,820 |
| Fees for services: Accounting | $30,382 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $34,957 |
| Advertising and promotion | $0 |
| Office expenses | $67,751 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $106,308 |
| Travel | $56,543 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $51,762 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $262,126 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $2,737,104 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $269,263 |
| Savings and temporary cash investments | $2,266,886 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $443,539 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $22,300 |
| Investments—program-related | $0 |
| Intangible assets | $481,222 |
| Other assets | $9,600 |
| Total assets | $3,492,810 |
| Accounts payable and accrued expenses | $27,068 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $511,032 |
| Total liabilities | $538,100 |
| Net assets without donor restrictions | $2,954,710 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,492,810 |